Impact on Mortality of a Strategy Including Continuous Positive Airway Pressure Plus High Flow Nasal Cannula Oxygen Therapy Versus High Flow Nasal Cannula Oxygen Therapy Alone in Patients With de Novo Acute Hypoxemic Respiratory Failure: a Prospective, Randomized Controlled Trial.

Clinical trial NCT06213168 · RECRUITING

Trial details

NCT number: NCT06213168
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

De Novo Hypoxemic Acute Respiratory Failure (hARF)

Start date: 2025-08-19
Primary completion: 2026-12-01
Enrollment: 1084

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.